Latest News

Key factors predict gallbladder cancer on routine cholecystectomy


 

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed.

Key takeaway

  • A few key factors predict when gallbladder cancer will be found on routine cholecystectomy, allowing for better surgical planning and treatment.

Why this matters

  • More than 60% of gallbladder cancers are diagnosed incidentally following cholecystectomy for benign reasons.
  • Identifying predictors allows surgeons to send high-risk individuals for oncologic evaluation beforehand and to prepare for intraoperative frozen pathology and more appropriate surgery, including extended cholecystectomy and lymph node dissection.

Study design

  • The investigators analyzed 403,443 cholecystectomies in the American College of Surgeons’ NSQIP database from 2007 to 2017.
  • They used multivariable logistic regression to identify risk factors for gallbladder cancers.
  • Patients undergoing cholecystectomy for suspected or confirmed gallbladder cancer were excluded.

Key results

  • The incidence of gallbladder cancer was 0.11% (441 of 403,443 patients).
  • Preoperative factors significantly associated with gallbladder cancer included age older than 60 years (odds ratio [OR], 6.51), female sex (OR, 1.75), weight loss (OR, 2.58), and elevated alkaline phosphatase level (OR, 1.67).
  • Starting with or converting to an open approach – both potential indicators of more complex disease – were associated with seven times’ higher odds of gallbladder cancer (OR, 7.33; P < .001), as were longer operative times (127 minutes vs. 70.7 minutes; P < .001).

Limitations

  • There is a risk of selection bias regarding which patients were included in the database.
  • Presenting symptoms, preoperative imaging findings, and pathologic staging were not available.
  • The database did not record the reasons for choosing open surgery rather than laparoscopic surgery or for converting to an open approach.

Disclosures

  • There was no funding for the work, and the investigators did not disclose any relevant financial relationships.

This is a summary of a preprint research study, “Gallbladder Cancer Incidentally Found at Cholecystectomy: Perioperative Risk Factors,” led by Elizabeth Olecki of Penn State University, State College. The study has not been peer reviewed. The full text can be found at researchsquare.com. A version of this article first appeared on Medscape.com.

Recommended Reading

Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United States
MDedge Hematology and Oncology
Diagnosed too late
MDedge Hematology and Oncology
FDA approves first gene therapy for bladder cancer
MDedge Hematology and Oncology
Cancer clinics begin to accommodate patients demanding new cancer detection tests
MDedge Hematology and Oncology
‘Low-value’ prostate cancer screening prevalent in primary care
MDedge Hematology and Oncology
Oncologists may be too quick to refer patients to palliative care
MDedge Hematology and Oncology
People with cancer should be wary of taking dietary supplements
MDedge Hematology and Oncology
3D-printed tumor models could advance new cancer therapies
MDedge Hematology and Oncology
New cancer data spark outcry from patient advocates
MDedge Hematology and Oncology
Local therapies show promise for metastatic lung cancer
MDedge Hematology and Oncology